9
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: not found

      LRIG1 restricts growth factor signaling by enhancing receptor ubiquitylation and degradation.

      The EMBO Journal
      Binding Sites, Cell Line, Epidermal Growth Factor, pharmacology, Evolution, Molecular, Humans, Ligands, Membrane Glycoproteins, genetics, metabolism, Oncogene Proteins v-erbB, Phosphotyrosine, Proteasome Endopeptidase Complex, Protein Binding, Proto-Oncogene Proteins, Proto-Oncogene Proteins c-cbl, RNA, Messenger, Receptor, Epidermal Growth Factor, Signal Transduction, drug effects, Substrate Specificity, Ubiquitin, Ubiquitin-Protein Ligases

      Read this article at

      ScienceOpenPublisherPMC
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Kekkon proteins negatively regulate the epidermal growth factor receptor (EGFR) during oogenesis in Drosophila. Their structural relative in mammals, LRIG1, is a transmembrane protein whose inactivation in rodents promotes skin hyperplasia, suggesting involvement in EGFR regulation. We report upregulation of LRIG1 transcript and protein upon EGF stimulation, and physical association of the encoded protein with the four EGFR orthologs of mammals. Upregulation of LRIG1 is followed by enhanced ubiquitylation and degradation of EGFR. The underlying mechanism involves recruitment of c-Cbl, an E3 ubiquitin ligase that simultaneously ubiquitylates EGFR and LRIG1 and sorts them for degradation. We conclude that LRIG1 evolved in mammals as a feedback negative attenuator of signaling by receptor tyrosine kinases.

          Related collections

          Author and article information

          Comments

          Comment on this article